NasdaqGS - Nasdaq Real Time Price
USD
Gossamer Bio, Inc. (GOSS)
10.38
-0.31
(-2.90%)
At close: October 30 at 4:00:01 PM EDT
10.15
-0.23
(-2.22%)
Pre-Market: 3:13:25 AM EST
News headlines
Powered by Yahoo ScoutGossamer Bio has submitted an NDA (new drug application) for seralutinib, making FDA filing acceptance the next major catalyst. The company also completed a 1-for-80 reverse stock split and arranged milestone-linked financing, while analysts remain sharply divided over regulatory risk, dilution, and the drug’s Phase 3 data.
